Role of inflammatory markers as hepatocellular cancer selection tool in the setting of liver transplantation

Transl Gastroenterol Hepatol. 2017 Nov 21:2:95. doi: 10.21037/tgh.2017.10.04. eCollection 2017.

Abstract

Since the advent of the Milan criteria in 1996 and its widespread adoption for selection of patients with hepatocellular carcinoma (HCC) who would benefit from transplant, there has been an extensive hunt for the ideal clinical biomarker to predict HCC recurrence. This is because Milan lack does not include tumor biology indices and recurrence rates remain in the 15-20% range worldwide. While a 'silver-bullet' biomarker has not been found, several useful inflammatory markers have been identified and used in scoring systems that supersede Milan in their ability to predict HCC recurrence post liver transplantation (LT). In this review, we aim to summarize the role of inflammatory markers paly in the selection of HCC patients awaiting LT.

Keywords: Biomarker; hepatocellular carcinoma (HCC); inflammation; liver transplantation (LT).

Publication types

  • Review